DK1311260T3 - Lipaseinhibitorer til behandling af dyspepsi - Google Patents

Lipaseinhibitorer til behandling af dyspepsi

Info

Publication number
DK1311260T3
DK1311260T3 DK01980222T DK01980222T DK1311260T3 DK 1311260 T3 DK1311260 T3 DK 1311260T3 DK 01980222 T DK01980222 T DK 01980222T DK 01980222 T DK01980222 T DK 01980222T DK 1311260 T3 DK1311260 T3 DK 1311260T3
Authority
DK
Denmark
Prior art keywords
dyspepsia
treatment
lipase inhibitors
lipase
inhibitors
Prior art date
Application number
DK01980222T
Other languages
English (en)
Inventor
Christine Feinle-Bisset
Hans Lengsfeld
Thomas Rades
Michael Fried
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1311260T3 publication Critical patent/DK1311260T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK01980222T 2000-08-09 2001-07-28 Lipaseinhibitorer til behandling af dyspepsi DK1311260T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00117088 2000-08-09
PCT/EP2001/008776 WO2002011719A2 (en) 2000-08-09 2001-07-28 Lipase inhibitors for the treatment of dyspepsia

Publications (1)

Publication Number Publication Date
DK1311260T3 true DK1311260T3 (da) 2008-06-23

Family

ID=8169476

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01980222T DK1311260T3 (da) 2000-08-09 2001-07-28 Lipaseinhibitorer til behandling af dyspepsi

Country Status (17)

Country Link
US (1) US6534539B2 (da)
EP (1) EP1311260B1 (da)
JP (2) JP4727901B2 (da)
KR (1) KR100494245B1 (da)
CN (1) CN1323661C (da)
AR (1) AR030132A1 (da)
AT (1) ATE390920T1 (da)
AU (2) AU1212002A (da)
BR (1) BR0113101A (da)
CA (1) CA2417607C (da)
DE (1) DE60133470T2 (da)
DK (1) DK1311260T3 (da)
ES (1) ES2304132T3 (da)
MX (1) MXPA03001182A (da)
PT (1) PT1311260E (da)
WO (1) WO2002011719A2 (da)
ZA (1) ZA200300845B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1803714A1 (en) * 2005-12-27 2007-07-04 KRKA, tovarna zdravil, d.d., Novo mesto Process for preparing crystalline forms of orlistat
WO2010042499A1 (en) * 2008-10-06 2010-04-15 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
US20140116916A1 (en) * 2012-10-31 2014-05-01 2294719 Ontario Limited Therapy for Constipation
WO2014104871A1 (en) * 2012-12-24 2014-07-03 N.V. Nutricia Method for improving postprandial fat digestion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1328881C (en) 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
CA1270837A (en) 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
CA2035972C (en) 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
US5274143A (en) 1991-07-23 1993-12-28 Hoffmann-La Roche Inc. Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione
US6004996A (en) 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
ATE293970T1 (de) 1998-08-14 2005-05-15 Hoffmann La Roche Lipasehemmer enthaltende pharmazeutische zusammensetzungen
CN1152680C (zh) 1998-08-14 2004-06-09 霍夫曼-拉罗奇有限公司 含有脂酶抑制剂和壳聚糖的药物组合物

Also Published As

Publication number Publication date
KR20030029811A (ko) 2003-04-16
DE60133470T2 (de) 2009-05-07
JP2004505914A (ja) 2004-02-26
KR100494245B1 (ko) 2005-06-13
JP2008120821A (ja) 2008-05-29
ES2304132T3 (es) 2008-09-16
PT1311260E (pt) 2008-05-02
AU2002212120B2 (en) 2006-05-11
AR030132A1 (es) 2003-08-13
US20020040049A1 (en) 2002-04-04
US6534539B2 (en) 2003-03-18
CN1446087A (zh) 2003-10-01
DE60133470D1 (de) 2008-05-15
EP1311260A2 (en) 2003-05-21
WO2002011719A2 (en) 2002-02-14
MXPA03001182A (es) 2003-06-30
EP1311260B1 (en) 2008-04-02
CA2417607A1 (en) 2002-02-14
JP4850821B2 (ja) 2012-01-11
AU1212002A (en) 2002-02-18
WO2002011719A3 (en) 2002-06-20
CA2417607C (en) 2008-01-29
CN1323661C (zh) 2007-07-04
JP4727901B2 (ja) 2011-07-20
ZA200300845B (en) 2004-04-30
BR0113101A (pt) 2003-06-24
ATE390920T1 (de) 2008-04-15

Similar Documents

Publication Publication Date Title
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
IS2532B (is) Aðferð til að afsalta sjó
DK1257954T3 (da) Fremgangsmåde til fordeling af forsendelser
CY2007029I1 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
DK1073658T3 (da) Pyrazolopyrimidinon-cGMP PDE5-inhibitorer til behandling af sexualforstyrrelse
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK2308507T3 (da) Fremgangsmåder til behandling af præeklampsi
DK1307263T3 (da) Hidtil ukendt anvendelse af lipaseinhibitorer
DK1309581T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1324970T3 (da) Retinoider til behandling af emfysem
DK1206436T3 (da) Retinoider til behandling af emfysem
DK2189162T3 (da) Fremgangsmåder til behandling af cellulære proliferative forstyrrelser
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
DK1294659T3 (da) Fremgangsmåde til isolering af katamin
DK1296970T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1169271T3 (da) Fremgangsmåde til remediering af vandförende lag
DK1200114T3 (da) PPAR delta inhibitorer til behandling af kardiovaskulære sygdomme
NO20031739D0 (no) Fremgangsmåte for rensing av plavastatin
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DK1311260T3 (da) Lipaseinhibitorer til behandling af dyspepsi
DK1286940T3 (da) Fremgangsmåde til fluormethylering af alkoholer
DK1468686T3 (da) S-methyl-dihydro-ziprasidon til behandling af psykiatriske lidelser